Zuhair V, Obaid M, Mustafa M, Shafique M, Rangwala B, Shakil A
J Diabetes Metab Disord. 2024; 23(1):1337-1349.
PMID: 38932816
PMC: 11196528.
DOI: 10.1007/s40200-024-01431-5.
Krall J, Ng J, Mehrotra N, Ruppert K, Siminerio L
touchREV Endocrinol. 2024; 20(1):52-57.
PMID: 38812671
PMC: 11132646.
DOI: 10.17925/EE.2024.20.1.10.
Alsaidan A, Alsaidan O, Mallhi T, Khan Y, Alzarea A, Alanazi A
J Clin Med. 2023; 12(10).
PMID: 37240580
PMC: 10219224.
DOI: 10.3390/jcm12103474.
Al Futaisi A, Alosali M, Al-Kazrooni A, Al-Qassabi S, Al-Gharabi S, Panchatcharam S
Sultan Qaboos Univ Med J. 2022; 22(4):525-531.
PMID: 36407689
PMC: 9645517.
DOI: 10.18295/squmj.6.2021.086.
Abebe A, Wobie Y, Kebede B, Wale A, Destaw A, Ambaye A
J Diabetes Metab Disord. 2022; 21(1):455-461.
PMID: 35673465
PMC: 9167384.
DOI: 10.1007/s40200-022-00995-4.
Visual impairment and its predictors among people living with type 2 diabetes mellitus at Dessie town hospitals, Northeast Ethiopia: institution-based cross-sectional study.
Seid M, Ambelu A, Diress M, Yeshaw Y, Akalu Y, Dagnew B
BMC Ophthalmol. 2022; 22(1):52.
PMID: 35114950
PMC: 8815255.
DOI: 10.1186/s12886-022-02292-3.
Cyclothymic Temperament is Associated with Poor Medication Adherence and Disordered Eating in Type 2 Diabetes Patients: A Case-Control Study.
Yamamoto T, Sakurai K, Watanabe M, Sakuma I, Kanahara N, Shiina A
Diabetes Ther. 2021; 12(9):2611-2624.
PMID: 34331669
PMC: 8384994.
DOI: 10.1007/s13300-021-01121-y.
Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus.
Weiss T, Iglay K, Gulati T, Rajpathak S, Yang L, Blonde L
BMJ Open Diabetes Res Care. 2021; 9(1).
PMID: 34167954
PMC: 8230991.
DOI: 10.1136/bmjdrc-2021-002127.
Combination of disease duration-to-age at diagnosis and hemoglobin A1c-to-serum C-peptide reactivity ratios predicts patient response to glucose-lowering medication in type 2 diabetes: A retrospective cohort study across Japan (JDDM59).
Kanatsuka A, Sato Y, Higashi Y, Goto Y, Kawai K, Maegawa H
J Diabetes Investig. 2021; 12(11):1967-1977.
PMID: 33837666
PMC: 8565405.
DOI: 10.1111/jdi.13558.
Factors Associated with Glycaemic Control among Diabetic Patients Managed at an Urban Hospital in Hanoi, Vietnam.
Thuy L, Nam H, Thi Ha An T, San B, Ngoc T, Trung L
Biomed Res Int. 2021; 2021:8886904.
PMID: 33708998
PMC: 7932774.
DOI: 10.1155/2021/8886904.
The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction.
Phillip M, Bergenstal R, Close K, Danne T, Garg S, Heinemann L
Diabetes Technol Ther. 2020; 23(2):146-154.
PMID: 32905711
PMC: 8098767.
DOI: 10.1089/dia.2020.0375.
Factors that Correlate with Poor Glycemic Control in Type 2 Diabetes Mellitus Patients with Complications.
Haghighatpanah M, Mozaffari Nejad A, Haghighatpanah M, Thunga G, Mallayasamy S
Osong Public Health Res Perspect. 2018; 9(4):167-174.
PMID: 30159222
PMC: 6110332.
DOI: 10.24171/j.phrp.2018.9.4.05.
Magnitude of glycemic control and its associated factors among patients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
Tekalegn Y, Addissie A, Kebede T, Ayele W
PLoS One. 2018; 13(3):e0193442.
PMID: 29505602
PMC: 5837131.
DOI: 10.1371/journal.pone.0193442.
Screening for celiac disease in poorly controlled type 2 diabetes mellitus: worth it or not?.
Kizilgul M, Ozcelik O, Beysel S, Akinci H, Kan S, Ucan B
BMC Endocr Disord. 2017; 17(1):62.
PMID: 28985731
PMC: 5639597.
DOI: 10.1186/s12902-017-0212-4.
Using Routine Data to Categorize Poor Control Diabetic Patients: An Application of Cluster Analysis Technique.
Abolhassani Shahreza F, Hazar N
Iran J Public Health. 2017; 46(1):120-127.
PMID: 28451537
PMC: 5401921.
Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association.
Young-Hyman D, De Groot M, Hill-Briggs F, Gonzalez J, Hood K, Peyrot M
Diabetes Care. 2016; 39(12):2126-2140.
PMID: 27879358
PMC: 5127231.
DOI: 10.2337/dc16-2053.
Delay of insulin initiation in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycemic agents (analysis of patient- and physician-related factors): A prospective observational DIPP-FACTOR study in Korea.
Kim S, Kim N, Ku B, Shon H, Kim D, Park T
J Diabetes Investig. 2016; 8(3):346-353.
PMID: 27712034
PMC: 5415458.
DOI: 10.1111/jdi.12581.
Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline data.
Linetzky B, Curtis B, Frechtel G, Montenegro Jr R, Escalante Pulido M, Stempa O
Diabetol Metab Syndr. 2016; 8:41.
PMID: 27453733
PMC: 4957288.
DOI: 10.1186/s13098-016-0157-1.
Antidiabetic activity of the chemical constituents of Combretum dolichopetalum root in mice.
Uzor P, Osadebe P
EXCLI J. 2016; 15:290-6.
PMID: 27298614
PMC: 4897660.
DOI: 10.17179/excli2016-252.
Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc).
Polinski J, Kim S, Jiang D, Hassoun A, Shrank W, Cos X
BMC Endocr Disord. 2015; 15:46.
PMID: 26353820
PMC: 4563845.
DOI: 10.1186/s12902-015-0044-z.
